The bioeconomy is an economic system that uses biological resources like plants, animals, biomass, and organic waste to produce food, energy, and services. In Indonesia, this sector includes industries like agroforestry and aquaculture, and it’s already attracted up to USD 11.76 billion in private funding across Southeast Asia.

This figure didn’t come out of nowhere. The Indonesian government has made the bioeconomy a key part of the 2025–2045 National Long-Term Development Plan (RPJPN), and they’re offering tax breaks and other incentives for the agriculture and forestry sectors, as well as co-investment initiatives through Danantara Indonesia.

INTRA Institute, a think tank division of Angin Dampak Jaya (ADJ), has figured out where this capital is going, who’s driving it, and what factors shape investor confidence. This is all explained in a report titled Bioeconomy in Indonesia: Private Investor Appetite and Preferences.

The Capital Is There, But Not Labeled “Bioeconomy” 

One of the report’s most significant findings is that private investors have already been putting a lot of money into sectors closely linked to the bioeconomy, even though they don’t use the term. They’re calling it agrifood innovation, sustainable materials, or circular economy solutions, and at the end of the day, it’s all about scalable businesses based on biological resources with clear revenue models.

The five subsectors with the most funding are Agriculture at USD 10.43 billion, Farming at USD 10.27 billion, AgTech at USD 9.92 billion, Food and Beverage at USD 0.50 billion, and Biotechnology at USD 0.48 billion. These figures represent real businesses that have already secured investment, like JALA and Umitron, which are technology-based aquaculture companies; Sayurbox, which is an agricultural digital marketplaces; and Wilmar International and Axelum Resources, which are commodity processing companies.

This pattern of capital flows shows that investment in Indonesia’s bioeconomy is already taking place, even if it isn’t always labeled as such.

Who Is Driving This Capital?

According to the 2025 investor portfolio database, the five investors with the biggest portfolios in bioeconomy-aligned sectors are 500 Global and Antler, each with investments in 11 companies. Following behind are 144 Ventures with eight companies, as well as East Ventures and Alpha JWC Ventures with seven companies each. Most of the top 15 investors are based in Singapore, and their continued participation also shows that the businesses they fund are doing well.

To understand investor sentiment in this sector, it’s important to recognize that private investors aren’t a homogeneous group. The INTRA Institute report talks about at least four types of investors who are active in this area, and each of them has different characteristics:

• Venture capital firms are the most active players, focusing on scalable businesses with clear revenue potential
• Private equity firms usually invest in more mature companies and expect more structured financial returns
• Asian family offices tend to be more cautious, often separating philanthropic activities from their core investments, which limits their exposure to the bioeconomy sector
• Institutional investors with ESG mandates use sustainability assessment tools such as Sustainalytics and RepRisk to evaluate non-financial risks, and often invest in bioeconomy-related sectors without specifically labeling them as “bioeconomy” investments

These differences in investor profiles are important because they determine how a bioeconomy business should position itself when seeking funding. A business that’s attractive to venture capital might not be attractive to a family office, and vice versa.

Factors Shaping Investor Sentiment

The INTRA Institute report notes that investors stay away from this sector because of the label itself. Instead, there are three more basic factors driving capital flows into sectors that intersect with the bioeconomy.

The first is Indonesia’s structural fundamentals. The country’s population is growing, its middle class is expanding, digital adoption is increasing, and domestic consumption is on the rise. This creates a stable demand. These factors are what initially attract investors to view Indonesia as a viable long-term market.

Technology-based business models is the second factor. Investors are into approaches that measurably improve productivity and margins, like data-driven farming, IoT-based precision input solutions, and digital supply chain management.

Companies like Chickin and Rize in the livestock sector, and Eratani in agriculture, are considered good examples because of their ability to increase yields while improving operational efficiency. This shows what bioeconomy investment goals mean for private investors: not just environmental impact, but also measurable and scalable business growth.

The third factor is value chain integration. Businesses that manage their value chains from upstream to downstream are viewed as more competitive because they have more control over quality and margins. They also make it easier to improve conditions for farmers and producers at the start of the process.

From the investor’s point of view, these three things shape how they see the risks of bioeconomy investments. The sector has its risks. However, they are considered manageable as long as the business model is solid and the target market is big enough.

Where Government and Private Capital Meet 

One of the key factors affecting investor confidence in the bioeconomy sector discussed in the report is government policy. Investors want to see governments not only issuing regulations, but also committing capital to the same sectors as a signal of long-term commitment. The Indonesian government has introduced a few financial incentives for businesses in this sector:

• VAT exemptions for the import of seeds and seedlings in the agriculture, forestry, fisheries, and livestock sectors
• A 30% net income reduction for investments in the forestry sector
• Import duty exemptions and VAT relief for goods used in nature conservation activities

Beyond fiscal incentives, government commitment is also reflected through Danantara Indonesia, which conducts co-investments in bioeconomy-aligned sectors, including downstream plantation industries and food security initiatives. When the government joins in as a co-investor, it changes the risk-return profile that private investors look at, which strengthens the overall bioeconomy market outlook.

A Bioeconomy Investment Landscape in Motion 

The ANGIN Advisory report emphasizes that bioeconomy investment in Indonesia should be positioned at the intersection of three elements: Indonesia’s unique resource advantages, existing private investor interest, and policies that encourage private capital inflows.

The report’s mapping shows that bioeconomy investment trends are heating up. Investors are already moving capital into relevant sectors, and policy support is getting stronger, and the overall bioeconomy market outlook points toward continued growth.  

If you want to know more about the analysis, including investor profiles, business pipelines, and the implications for industry players, check out the full Bioeconomy Report on Investor Appetite in Indonesia Launch on the ANGIN Foundation website.